Atlas Iron Limited to re-start production: What you need to know

Embattled iron ore miner, Atlas Iron Limited (ASX: AGO), plans to restart production and lower costs dramatically.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

So much for low iron ore prices forcing junior producers out of the market…

Following its decision to voluntarily suspend trading of its shares on the ASX, pending the outcome of an operational and financial outlook review, Atlas Iron Limited (ASX: AGO) today announced it will restart production at its West-Australian mines.

Atlas said it has already recommenced mining at the Abydos mine, whilst the Wodgina mine will recommence next week.

Counting down the days…

According to an ASX media release, Atlas formed a "collaboration agreement" which applies to the two aforementioned mines. Combined the Abydos and Wodgina mines produce approximately 9.0 million tonnes per annum (mtpa) of iron ore.

The collaboration agreement will reduce Atlas' breakeven cost to $US50 per tonne. This figure is however subject to an AUDUSD exchange rate of 78.5 cents and a production run rate of between 14 and 15mtpa. It compares "to the current benchmark price of approximately USD$60/dmt," the media release stated.

The company also said the restart of the Mt Webber mine in September will target a similar cost base, "with shipping from Sept Qtr targeting an additional ~6Mtpa and a total Pilbara production target of 14-15Mtpa by year-end."

To build balance sheet flexibility, Atlas said it plans to conduct a capital raising which could include participation from shareholders, institutional and sophisticated investors as well as certain directors and contractors. Details of the raising will be announced prior to a meeting scheduled for June 19, 2015.

"This is nothing short of an outstanding result for everyone involved directly and indirectly with Atlas," Chairman David Flanagan said. "We'd also like to thank our collaborating contractors for their engagement."

Parties to the two-year collaboration agreement include: MACA Ltd (ASX: MLD), QUBE Holdings Ltd (ASX: QUB) and McAleese Ltd (ASX: MCS). Interestingly, if Atlas generates a positive operating cash flow from the Abydos and Wodgina mines it'll pay 25% of the positive net cashflow to these contractors.

Another key point of the agreement read:

"The parties will meet monthly for the period of the agreement to assess the rolling 3 month forward schedule to determine operating margins. Where forward sales that generate positive operating margins are not possible or minimum volumes have not been delivered in the previous or coming month, collaborating contractors and/or Atlas may either recommend suspension or termination of the collaboration agreement with 30 days' notice."

Should you take part in Atlas Iron's capital raising?

I can only feel worried for the contractors, employees and stakeholders involved in some of these small iron ore miners because, chances are, tougher times lay ahead. It pains me to say it but if I were a shareholder in Atlas, I'd look to get out of the stock whichever way was quickest and most lucrative.

Even at $US50 per tonne; Atlas will not be competitive with the likes of Rio Tinto Limited (ASX: RIO), BHP Billiton Limited (ASX: BHP), Brazil's Vale and Fortescue Metals Group Limited (ASX: FMG). Each of whom are producing hundreds of millions of tonnes of iron ore at a cash cost significantly below $US50 per tonne (some lower $US20 per tonne!).

Motley Fool contributor Owen Raskiewicz has no position in any stocks mentioned. Owen welcomes your feedback on Google plus (see below) or you can follow him on Twitter @ASXinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »